# DrugAgent：借助 LLM 多智能体协作，实现 AI 辅助药物发现编程的自动化

发布时间：2024年11月23日

`Agent` `药物发现`

> DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration

# 摘要

> 近期，大型语言模型（LLMs）的发展为加速药物发现进程开辟了新道路。尽管潜力巨大，但仍存在一些关键难题尚未解决，尤其是在将理论构想转化为制药研究这一高度专业化领域的实际应用方面，这限制了从业者借助药物发现领域的最新人工智能成果。为此，我们推出了 DrugAgent，这是一个致力于实现药物发现中机器学习（ML）编程自动化的多智能体框架。DrugAgent 通过明确特定需求、构建特定领域工具来融合领域专业知识，同时系统地探索不同思路以寻求有效解决方案。初步的案例研究显示，DrugAgent 有能力克服 LLMs 在药物发现中面临的关键局限，推动向人工智能驱动的创新发展。比如，DrugAgent 能够从头到尾完成机器学习编程流程，涵盖从数据获取到 ADMET 预测任务的性能评估，最终选出最优模型，其中随机森林模型在使用 PAMPA 数据集预测吸收时，F1 分数达到 0.92。

> Recent advancements in Large Language Models (LLMs) have opened new avenues for accelerating drug discovery processes. Despite their potential, several critical challenges remain unsolved, particularly in translating theoretical ideas into practical applications within the highly specialized field of pharmaceutical research, limiting practitioners from leveraging the latest AI development in drug discovery. To this end, we introduce DrugAgent, a multi-agent framework aimed at automating machine learning (ML) programming in drug discovery. DrugAgent incorporates domain expertise by identifying specific requirements and building domain-specific tools, while systematically exploring different ideas to find effective solutions. A preliminary case study demonstrates DrugAgent's potential to overcome key limitations LLMs face in drug discovery, moving toward AI-driven innovation. For example, DrugAgent is able to complete the ML programming pipeline end-to-end, from data acquisition to performance evaluation for the ADMET prediction task, and finally select the best model, where the random forest model achieves an F1 score of 0.92 when predicting absorption using the PAMPA dataset.

[Arxiv](https://arxiv.org/abs/2411.15692)